PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line (Q39858791)

15 September 2017

title

PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line (English)

1 reference

15 September 2017

0 references

1

Charity Nofziger

1 reference

15 September 2017

Kathleen K Brown

2

1 reference

15 September 2017

Chari D Smith

3

1 reference

15 September 2017

Wallace Harrington

4

1 reference

15 September 2017

David Murray

5

1 reference

15 September 2017

John Bisi

6

1 reference

15 September 2017

Thalia T Ashton

7

1 reference

15 September 2017

Frank P Maurio

8

1 reference

15 September 2017

Kameljit Kalsi

9

1 reference

15 September 2017

T Aaron West

10

1 reference

15 September 2017

Deborah Baines

11

1 reference

15 September 2017

Bonnie L Blazer-Yost

12

1 reference

15 September 2017

publication date

29 April 2009

1 reference

American Journal of Physiology - Renal Physiology

15 September 2017

published in

1 reference

15 September 2017

volume

297

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

F55-62

1 reference

Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Characterization of hormone-stimulated Na+ transport in a high-resistance clone of the MDCK cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Can PPARgamma agonists have a role in the management of obesity-related hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Structure and function of cyclic nucleotide-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Novel PPARgamma agonists GI 262570, GW 7845, GW 1929, and pioglitazone decrease calcium channel function and myogenic tone in rat mesenteric arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

The Water and Nonelectrolyte Permeability Induced in Thin Lipid Membranes by the Polyene Antibiotics Nystatin and Amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Chloride channel diseases resulting from impaired transepithelial transport or vesicular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Salt handling and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Renal epithelial Cl‐ secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Rosiglitazone Activates Renal Sodium- and Water-Reabsorptive Pathways and Lowers Blood Pressure in Normal Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Vasopressin-stimulated chloride transport in transimmortalized mouse cell lines derived from the distal convoluted tubule and cortical and inner medullary collecting ducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Molecular recognition of fatty acids by peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00090.2009

10.1152/AJPRENAL.00090.2009

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference